Jimmy Shan

Stock Analyst at RBC Capital

(3.02)

# 1,343

Out of 4,944 analysts

14

Total ratings

100%

Success rate

22.82%

Average return

Main Sectors:

Real Estate Healthcare

Top Industries:

Real Estate Services Biotechnology

Stocks Rated by Jimmy Shan

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CIGI Colliers International Group	Maintains: Outperform	$175 → $185	$158.00	+17.09%	13	Aug 1, 2025
	TRML Tourmaline Bio	Initiates: Outperform	$58	$21.43	+170.65%	1	Feb 24, 2025

Colliers International Group

Aug 1, 2025

Maintains: Outperform

Price Target: $175 → $185

Current: $158.00

Upside: +17.09%

Tourmaline Bio

Feb 24, 2025

Initiates: Outperform

Price Target: $58

Current: $21.43

Upside: +170.65%